Copy number loss or silencing of apoptosis-effector genes in cancer

Gene

Volumn 554, Issue 1, 2015, Pages 50-57

  Mauro, James A ^a   Butler, Shanitra N ^a   Ramsamooj, Michael ^a   Blanck, George ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Apoptosis effector genes; Copy number variation; COSMIC; ENCODE; Gene dosage; TCGA

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; APOPTOSIS EFFECTOR GENE; ARTICLE; BREAST CARCINOMA; CARCINOGENESIS; CARCINOMA; CECUM CARCINOMA; CHROMATIN STRUCTURE; COLON ADENOCARCINOMA; COPY NUMBER VARIATION; DATA MINING; ENDOMETRIUM CARCINOMA; GENE; GENE DOSAGE; GENE SILENCING; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; NEOPLASM; OVARY; PANCREAS CARCINOMA; PANCREAS CELL; PROLIFERATION EFFECTOR GENE; RECTUM CARCINOMA; SQUAMOUS CELL CARCINOMA; BIOLOGY; CELL PROLIFERATION; CHROMATIN; GENE EXPRESSION REGULATION; GENETICS; HUMAN GENOME; METABOLISM; MUTATION;

CHROMATIN; PROTEIN P53; TP53 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

APOPTOSIS; CELL PROLIFERATION; CHROMATIN; COMPUTATIONAL BIOLOGY; DATA MINING; DNA COPY NUMBER VARIATIONS; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENOME, HUMAN; HUMANS; MUTATION; NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84912524004     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.10.021     Document Type: Article

References (13)

1. Banerjee D., Ercikan-Abali E., Waltham M., Schnieders B., Hochhauser D., Li W.W., Fan J., Gorlick R., Goker E., Bertino J.R. Molecular mechanisms of resistance to antifolates, a review. Acta Biochim. Pol. 1995, 42(4):457-464.
2. Cheng I., Levin A.M., Tai Y.C., Plummer S., Chen G.K., Neslund-Dudas C., Casey G., Rybicki B.A., Witte J.S. Copy number alterations in prostate tumors and disease aggressiveness. Genes Chromosomes Cancer 2012, 51(1):66-76.
3. Ciriello G., Miller M.L., Aksoy B.A., Senbabaoglu Y., Schultz N., Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat. Genet. 2013, 45(10):1127-1133.
4. de Clare M., Oliver S.G. Copy-number variation of cancer-gene orthologs is sufficient to induce cancer-like symptoms in Saccharomyces cerevisiae. BMC Biol. 2013, 11:24.
5. De Vita S., Canzonetta C., Mulligan C., Delom F., Groet J., Baldo C., Vanes L., Dagna-Bricarelli F., Hoischen A., Veltman J., Fisher E.M., Tybulewicz V.L., Nizetic D. Trisomic dose of several chromosome 21 genes perturbs haematopoietic stem and progenitor cell differentiation in Down's syndrome. Oncogene 2010, 29(46):6102-6114.
6. Field S.J., Tsai F.Y., Kuo F., Zubiaga A.M., Kaelin W.G., Livingston D.M., Orkin S.H., Greenberg M.E. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 1996, 85(4):549-561.
7. Forbes S.A., Bindal N., Bamford S., Cole C., Kok C.Y., Beare D., Jia M., Shepherd R., Leung K., Menzies A., Teague J.W., Campbell P.J., Stratton M.R., Futreal P.A. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res. 2011, 39:D945-950. (Database issue).
8. Huang M., Weiss W.A. Neuroblastoma and MYCN. Cold Spring Harb. Perspect. Med. 2013, 3(10):a014415.
9. Mauro J.A., Blanck G. Functionally distinct gene classes as bigger or smaller transcription factor traps: a possible stochastic component to sequential gene expression programs in cancer. Gene 2014, 536(2):398-406.
10. Rosenbloom K.R., Sloan C.A., Malladi V.S., Dreszer T.R., Learned K., Kirkup V.M., Wong M.C., Maddren M., Fang R., Heitner S.G., Lee B.T., Barber G.P., Harte R.A., Diekhans M., Long J.C., Wilder S.P., Zweig A.S., Karolchik D., Kuhn R.M., Haussler D., Kent W.J. ENCODE data in the UCSC Genome Browser: year 5 update. Nucleic Acids Res. 2013, 41:D56-63. (Database issue).
11. Sikora E., Grassilli E., Radziszewska E., Bellesia E., Barbieri D., Franceschi C. Transcription factors DNA-binding activity in rat thymocytes undergoing apoptosis after heat-shock or dexamethasone treatment. Biochem. Biophys. Res. Commun. 1993, 197(2):709-715.
12. Slovak M.L., Bedell V., Hsu Y.H., Estrine D.B., Nowak N.J., Delioukina M.L., Weiss L.M., Smith D.D., Forman S.J. Molecular karyotypes of Hodgkin and Reed-Sternberg cells at disease onset reveal distinct copy number alterations in chemosensitive versus refractory Hodgkin lymphoma. Clin. Cancer Res. 2011, 17(10):3443-3454.
13. Stenman G., Andersson M.K., Andren Y. New tricks from an old oncogene: gene fusion and copy number alterations of MYB in human cancer. Cell Cycle 2010, 9(15):2986-2995.